Radiation oncologist Stephen Hahn confirmed as FDA commissioner

By News Release


The U.S. Senate has voted Dec. 12 to confirm radiation oncologist Stephen Hahn, MD, FASTRO, as the next commissioner of the Food and Drug Administration (FDA).

“We applaud the U.S. Senate for confirming Dr. Stephen Hahn as the nation’s next Commissioner of the Food and Drug Administration," said Theodore L. DeWeese, MD, FASTRO, Chair of the ASTRO Board of Directors. "Dr. Hahn’s impressive background as a triple board-certified physician in medicine, medical oncology and radiation oncology, coupled with his broad administrative experiences, will allow him to ably lead the thousands of career professionals charged with ensuring U.S. consumer protection and public health. 

“Our support and respect for Dr. Hahn is based on his proven commitment to patients, science-based decision-making, and consumer health and safety," add Dr. DeWeese. "We look forward to his leadership as he steps into this critically important role as FDA Commissioner.”

Back To Top

Radiation oncologist Stephen Hahn confirmed as FDA commissioner.  Appl Rad Oncol. 

By News Release| December 13, 2019
Categories:  Section

About the Author

News Release

News Release


Copyright © Anderson Publishing, Ltd

    Agility CMS